Diagnosis, treatment, and outcome of primary CNS lymphoma—a single-center experience

[1] Abrey LE(2005)Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma J Clin Oncol 23 5034-5043

[2] Batchelor TT(2006)Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model J Clin Oncol 24 5711-5715

[3] Ferreri AJ(2021)Liquid biopsy and other non-invasive diagnostic measures in PCNSL Cancers (Basel) 13 2665-620

[4] Gospodarowicz M(1998)Primary central nervous system lymphoma: age and performance status are more important than treatment modality Int J Radiat Oncol Biol Phys 41 615-340

[5] Pulczynski EJ(2002)Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients Eur Radiol 12 329-68

[6] Zucca E(2018)Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000–2013 Eur J Haematol 100 61-1901

[7] Smith JR(2011)Spectrum of cancer risk among US solid organ transplant recipients JAMA 306 1891-272

[8] Korfel A(2003)Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience J Clin Oncol 21 266-577

[9] Soussain C(2017)Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents Hematol Am Soc Hematol Educ Program 2017 565-2085

[10] DeAngelis LM(2011)Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly Ann Oncol 22 2080-2418

[1] Abrey LE(2005)Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma J Clin Oncol 23 5034-5043

[2] Batchelor TT(2006)Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model J Clin Oncol 24 5711-5715

[3] Ferreri AJ(2021)Liquid biopsy and other non-invasive diagnostic measures in PCNSL Cancers (Basel) 13 2665-620

[4] Gospodarowicz M(1998)Primary central nervous system lymphoma: age and performance status are more important than treatment modality Int J Radiat Oncol Biol Phys 41 615-340

[5] Pulczynski EJ(2002)Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients Eur Radiol 12 329-68

[6] Zucca E(2018)Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000–2013 Eur J Haematol 100 61-1901

[7] Smith JR(2011)Spectrum of cancer risk among US solid organ transplant recipients JAMA 306 1891-272

[8] Korfel A(2003)Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience J Clin Oncol 21 266-577

[9] Soussain C(2017)Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents Hematol Am Soc Hematol Educ Program 2017 565-2085

[10] DeAngelis LM(2011)Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly Ann Oncol 22 2080-2418